Transplantation elicits a clonally diverse CD8+ T cell response that is comprised of potent CD43+ effectors

Cell Rep. 2023 Aug 29;42(8):112993. doi: 10.1016/j.celrep.2023.112993. Epub 2023 Aug 16.

Abstract

CD8+ T cells mediate acute rejection of allografts, which threatens the long-term survival of transplanted organs. Using MHC class I tetramers, we find that allogeneic CD8+ T cells are present at an elevated naive precursor frequency relative to other epitopes, only modestly increase in number after grafting, and maintain high T cell receptor diversity throughout the immune response. While antigen-specific effector CD8+ T cells poorly express the canonical effector marker KLRG-1, expression of the activated glycoform of CD43 defines potent effectors after transplantation. Activated CD43+ effector T cells maintain high expression of the coreceptor induced T cell costimulator (ICOS) in the presence of CTLA-4 immunoglobulin (Ig), and dual CTLA-4 Ig/anti-ICOS treatment prolongs graft survival. These data demonstrate that graft-specific CD8+ T cells have a distinct response profile relative to anti-pathogen CD8+ T cells and that CD43 and ICOS are critical surface receptors that define potent effector CD8+ T cell populations that form after transplantation.

Keywords: CP: Immunology; alloimmunity; costimulation blockade; effector CD8(+) T cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies*
  • CD8-Positive T-Lymphocytes*
  • CTLA-4 Antigen
  • Epitopes
  • Interleukin-2
  • Transplantation, Homologous

Substances

  • CTLA-4 Antigen
  • Antibodies
  • Epitopes
  • Interleukin-2